-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on Protagonist Therapeutics, Raises Price Target to $117

Benzinga·01/30/2026 18:45:40
Listen to the news
HC Wainwright & Co. analyst Douglas Tsao maintains Protagonist Therapeutics (NASDAQ:PTGX) with a Buy and raises the price target from $80 to $117.